Interius Biotherapeutics
Jim leads analytical development at Interius, cutting across all scientific efforts at the company. Trained as a virologist, Jim has over 25 years of experience developing viral products for the prevention and treatment of disease. Jim comes to Interius from Altimmune, where he was Director of Scientific Affairs.
Previously, Jim led the cell and gene therapy standards development efforts at US Pharmacopeia. In previous roles at Advanced BioScience Laboratories and Foundation Fighting Blindness, he led translational science activities for the development of vaccines and biologics to prevent and treat infectious and retinal diseases. Jim has also held positions responsible for performing viral clearance and adventitious agent testing at Viromed Biosafety as well as AAV vector development and characterization at Genovo/Targeted Genetics.
Jim received his Bachelor of Science degree in Microbiology from Cornell University, his Master of Science in Microbiology from Colorado State University, and his PhD in Biomedical Sciences at the Mount Sinai School of Medicine.
This person is not in any offices
Interius Biotherapeutics
1 followers
Interius is an early-stage biotechnology company expanding the potential of cell and gene therapy by developing next-generation delivery technology based on inventions from the laboratory of Dr. Saar Gill at the University of Pennsylvania.